Seldon Capital’s Sanofi SNY Stock Holding History

Seldon Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,703	Closed	-$82.5K	–	217
2022 Q4	$82.5K	Hold	1,703	–	–	0.07%	93
2022 Q3	$65K	Hold	1,703	–	–	0.05%	111
2022 Q2	$85K	Hold	1,703	–	–	0.05%	99
2022 Q1	$87K	Hold	1,703	–	–	0.05%	113
2021 Q4	$85K	Buy	+1,703	New	+$84.2K	0.05%	117

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Seldon Capital's SNY Position: Q1 2023 in Review

Seldon Capital sold out of Sanofi (SNY) in Q1 2023, closing a stake of 1,703 shares — an estimated $82.5K sold.

Seldon Capital first reported a position in SNY in Q4 2021 and held it in 5 quarters. The position peaked at $87K in Q1 2022. 678 funds tracked by Wall St. Rank hold SNY as of Q1 2023.

Seldon Capital reported no remaining Sanofi position as of Q1 2023 after selling out during the quarter.
Seldon Capital sold 1,703 Sanofi shares in Q1 2023, an estimated $82.5K.
Seldon Capital first reported a position in Sanofi in Q4 2021 and held it in 5 quarters.
Seldon Capital's Sanofi position peaked at $87K in Q1 2022.
678 funds tracked by Wall St. Rank held Sanofi as of Q1 2023.

Based on Seldon Capital's 13F filing for Q1 2023, filed 12 May 2023.